World Health Day 2011: Antimicrobial Resistance 1 |1 | Prevention and Containment of Antimicrobial Resistance USE ANTIBIOTICS RATIONALLY.

Slides:



Advertisements
Similar presentations
World Health Day 2011.
Advertisements

East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
European Antibiotic Awareness Day 2013, 18 November 2013 European Antibiotic Awareness Day 2013 * Joining efforts to avoid a post-antibiotic era [Name.
Christine Lubinski Vice President for Global Health Infectious Diseases Society of America April 17, 2009 Germs Go Global Tuberculosis and HIV/TB Co-Infection.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
Combatting Antimicrobial Drug Resistance Dr Charles Penn Pandemic and Epidemic Diseases Health Security and Environment.
Role of the laboratory in disease surveillance
Update on Antimicrobial Resistance Allison McGeer, MD, FRCPC Mount Sinai Hospital
Regional initiative to sustain country achievement SEAR Krongthong Thimasarn Regional Adviser, Malaria World Health Organization Regional Office for South-
| Antimicrobial Resistance Global Report on Surveillance 2014 Global Action Plan to combat antimicrobial resistance.
The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January
What, Where, How and Action Steps… XDR-TB
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Prevention, Surveillance and Statistics of Resistance to Antibiotics
Patient’s needs driven R & D Agenda. Increasing Devastation of Leishmaniasis 88 countries in tropical and temperate regions 72 of them developing or least.
CLS 212 medical microbiology Mrs. Basmah Al-Maarik.
Session 13. The Role of the DTC in Containing Antimicrobial Resistance Drug and Therapeutics Committee.
Emerging infections and Health Protection In Scotland Looking to the future Kirsty Roy and Martin Donaghy Health Protection Scotland Scottish Government.
Did you know?. About 9.5 million people die each year due to global infectious diseases. Most of them are in third world countries.
Multidrug resistant organisms: What are we up against? Hans Jørn Kolmos MD DMSc Professor, consultant Department of Clinical Microbiology Odense University.
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
Key Strategies for Improving Use of Existing and New Antibiotics -the European Experience Otto Cars Professor Inf. Diseases, Uppsala University, Sweden.
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
Antimicrobial Stewardship
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
Antibiotics!.
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
Can the Application of the International Health Regulations to Antimicrobial Resistance Events Help to Preserve Antimicrobials? AMR 1, abstract N° 406.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Antibiotics and the Resident
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
Moving ahead with the Stop TB Strategy: where are we today? Dr Mario Raviglione Director, WHO Stop TB Department Joint Meeting of Core Teams and High Burden.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
1 Combating Drug Resistance Syed Khalid Saeed Bukhari.
ASDPE International Health Regulations (IHR 2005) Laboratory and Zoonosis update Dr Richard Brown, WHO Thailand Workshop on Laboratory Diagnosis for Zoonotic.
Antimicrobial resistance
European Centre for Disease Prevention and Control
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
Infectious Diseases and Global Public Health DR. Amjad Fathi El-Shanti MD,NPH,DR PH University of Palestine 2016.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
IMPORTANT ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE A Presentation By Ms R.Venkatajothi, MSc., MPhil, PhD Senior Lecturer Department of Microbiology Faculty.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
AMR containment in Thailand
Antimicrobial Stewardship
به نام و یاد خالق هستی هم او که آفرید شور و مستی.
Introduction to Antimicrobial Resistance
Dr.Mowna Karthick M.D MICROBIOLOGY
Antimicrobial Resistance (AMR)
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
E. Monee’ Carter-Griffin DNP, RN, ACNP-BC
به نام و یاد خالق هستی هم او که آفرید شور و مستی.
“An overview” 10th April 2018 at MOH SMT Now 27th April 2018 at NPHIL
Neonatal sepsis in Kilifi
World Health Day 2011.
Antimicrobial Resistance
Antimicrobial Resistance
Presentation transcript:

World Health Day 2011: Antimicrobial Resistance 1 |1 | Prevention and Containment of Antimicrobial Resistance USE ANTIBIOTICS RATIONALLY

World Health Day 2011: Antimicrobial Resistance 2 |2 | Resistance in microbes is a natural phenomenon Resistance is unresponsiveness to antimicrobial agents in standard doses A natural biological unstoppable phenomenon Resistance is generally slow to reverse or irreversible All antimicrobial agents have the potential to select drug-resistant subpopulations of microorganisms

World Health Day 2011: Antimicrobial Resistance 3 |3 | Resistance is accelerated through inappropriate use of antimicrobials – Standard treatment guidelines not provided to physicians or provided but not adhered to – Drugs available without prescription – Accessible but poor quality – Inadequate monitoring – Irrational self-administration or prescription Antimicrobial resistance

World Health Day 2011: Antimicrobial Resistance 4 |4 | Resistance is fallout of inappropriate use of antimicrobials in different settings In animals and plants: – Therapeutic and non-therapeutic (e.g. as growth promoters) In community acquired infections In hospital-associated infections Irrational use of antibiotics is the greatest driver of resistance – 50% of antibiotics are prescribed inappropriately – 50% of patients have poor compliance – 50% of populations do not have access to essential antibiotics

World Health Day 2011: Antimicrobial Resistance 5 |5 | Resistant organisms also move rapidly across borders through humans and the food-chain Two outbreaks of methicillin-resistant Staph. aureus (MRSA) in hospitals in Canada – Origin in North India Multidrug-resistant typhoid fever in USA – Originated in 6 countries (including India) MDR Salmonella schwarzengrund – Imported through Thai food into Denmark and the USA Multidrug resistant Mycobacteria Resistant malaria at Thai-Cambodia border Resistance in H1N1 and HIV are global concerns

World Health Day 2011: Antimicrobial Resistance 6 |6 | Resistance is negating “wonder” drugs

World Health Day 2011: Antimicrobial Resistance 7 |7 | Status of resistance in WHO’s South-East Asia Region Tuberculosis – MDR-TB < 3%: cases annually – XDR-TB: Reported from Bangladesh, India, Indonesia, Thailand

World Health Day 2011: Antimicrobial Resistance 8 |8 | Status of resistance in WHO’s South-East Asia Region – 400 million people at risk of infection with resistant parasites Malaria

World Health Day 2011: Antimicrobial Resistance 9 |9 | Status of resistance in WHO’s South-East Asia Region HIV and STIs – Data on HIV resistance being generated – STIs: Gonorrhoea widely resistant to penicillin & fluoroquinolones

World Health Day 2011: Antimicrobial Resistance 10 | Status of resistance in WHO’s South-East Asia Region Kala-azar – 60% resistance in pentavalent antimony and 25% in pentamidine

World Health Day 2011: Antimicrobial Resistance 11 | Status of resistance in SEAR-2 epidemic prone diseases Cholera – Resistance to Nalidixic acid, fluorazolidone, cotrimoxazole: India – Tetracycline resistance: India Shigellosis – Multidrug resistant, causing extensive outbreaks Typhoid fever – MDR Salmonella typhi prevalent all over Region – Causing 10% Case Fatality Rate (CFR) in children (preantibiotic era: 12.8%) Acute respiratory infections (pneumonias) – 69% of Strept pneumoniae resistant to penicillin in Thailand

World Health Day 2011: Antimicrobial Resistance 12 | Status of resistance in SEAR-3 Hospital-associated infections Staphylococcus aureus – >50% isolates in hospitals are methicillin-resistant – 48% of patients with bacteraemia died in Thailand Acinetobacter baumannii – >50% of patients infected with resistant strains die Pseudomonas, Klebsiella, Serratia – Multidrug-resistance, persist in hospital settings, and cause huge mortality morbidity

World Health Day 2011: Antimicrobial Resistance 13 | Resistance has huge negative impact on health Longer duration of illness Longer treatment Higher mortality Treatment with expensive drugs Increased burden on health system Negates technological advances in medical sector – Complex surgeries – Transplantations and other interventions Patient acts as reservoir of resistant organisms which are passed to community and health-care workers Huge economic impact

World Health Day 2011: Antimicrobial Resistance 14 | Resistance: A global public health issue ECDC:”antimicrobial resistance is possibly the single biggest threat facing the world in the area of infectious diseases”.the single biggest threat facing the world in the area of infectious diseases IHR (2005) – PHEIC World Alliance on Patient Safety Challenge III MDGs (HIV, TB and Malaria) Essential Drugs List (use in 120 countries) Several WHA Resolutions on rational use of drugs/antimicrobial resistance but little progress – WHA37.33 – WHA51.17 – WHA54.11 – WHA58.27

World Health Day 2011: Antimicrobial Resistance 15 | Resistance is a multifaceted problem Biological Behavioural Technical Economic Regulatory Educational

World Health Day 2011: Antimicrobial Resistance 16 | Superbugs* are visible manifestations of our prolonged failure to preserve antibiotics ** Methicillin resistant Staph aureus, MDR-and XDR Mycobacteria, ESBL producing Gram negative bacteria and NDM-1 producing enterobacteriaceae bacteria are few examples of superbugs because these fail to respond to large number of commonly used antibiotics Known but neglected. Need immediate action Known but inevitable

World Health Day 2011: Antimicrobial Resistance 17 | Possible solutions Discover new drugs faster than emergence of resistance Rationalize the use of available antimicrobial agents Prevent emergence of resistance by reducing selection pressure by appropriate control measures Promote discovery, development and dissemination of new antimicrobial agents

World Health Day 2011: Antimicrobial Resistance 18 | ? Bad bugs need new drugs

World Health Day 2011: Antimicrobial Resistance 19 | Possible solutions Discover new drugs faster than emergence of resistance Rationalize the use of available antimicrobial agents Prevent emergence of resistance by reducing selection pressure by appropriate control measures Promote discovery, development and dissemination of new antimicrobial agents Implementation requires a strategy with comprehensive national initiatives/plans

World Health Day 2011: Antimicrobial Resistance 20 | Regional Strategy on Antimicrobial Resistance Goal : To minimize the morbidity and mortality due to antimicrobial-resistant infection and to preserve the effectiveness of antimicrobial agents in the treatment and prevention of microbial infections. Rational Use of Antibiotics

World Health Day 2011: Antimicrobial Resistance 21 | Major activities  Establishment of national alliances against AMR  Designation of national focal points in MoH  Constitution of multisectoral National Steering Committee Governance Development and application of standard treatment guidelines in health and veterinary sectors Discourage non-therapeutic use of drugs in animals Restrictions on over-the-counter sale of antimicrobial agents Regulatory Surveillance of antimicrobial use and resistance Training prescribers for rational use of antimicrobials Reducing disease burden and infection control Undertaking operational research Capacity building Educating for adherence to recommended regimens Discouraging self-prescription Community participation

World Health Day 2011: Antimicrobial Resistance 22 | Will it work??? (There are success stories from Finland, France and some hospitals in the SEA Region) Seppalla et al. The Effect of Changes in the Consumption of Macrolide Antibiotics on Erythromycin Resistance in Group A Streptococci in Finland: New Eng J Med Volume 337: August 14, 1997August 14, 1997

World Health Day 2011: Antimicrobial Resistance 23 | We need to preserve this resource by working together Combating antimicrobial resistance: No action today, no cure tomorrow Antibiotics are a precious resource